Discover 1,399 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,399
Abatacept for the Treatment of Giant Cell Arteritis
for
Giant Cell Arteritis
Location: Cleveland OH, Toronto, Philadelphia PA, New York NY,
Sponsor: University of Pennsylvania
Sex: All
Age: 50+
Code: NCT04474847
Phase3, Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Cleveland OH, Detroit MI, Royal Oak MI, Ann Arbor MI,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
for
Acute Kidney Injury
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Cincinnati OH,
Sponsor: SeaStar Medical
Sex: All
Age: 18+
Code: NCT05758077
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Cleveland OH, Canton OH, Detroit MI, Pittsburgh PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Kidney Precision Medicine Project
for
Acute Kidney Failure, Acute Kidney Insufficiency,
Location: Cleveland OH, Baltimore MD, Chicago IL, New York NY,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04334707
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
for
Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic
Location: Cleveland OH, Philadelphia PA, Rochester MN, Marrero LA,
Sponsor: PharmaIN
Sex: All
Age: 18 - 70+
Code: NCT05490888
Phase1, Recruiting
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
for
Oral Squamous Cell Carcinoma
Location: Cleveland OH, Chicago IL, Miami FL, Duarte CA
Sponsor: Privo Technologies
Sex: All
Age: 18 - 70+
Code: NCT05893888
Phase2, Phase3, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Cleveland OH, Pittsburgh PA, Buffalo NY, Chicago IL,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
Remission From Stage D Heart Failure
for
Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Location: Cleveland OH, Louisville KY, Philadelphia PA,
Sponsor: University of Louisville
Sex: All
Age: 18 - 59
Code: NCT01774656
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Grand Rapids MI,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery
for
Open Abdominal Surgery
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT06409156
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Cleveland OH, Akron OH, Detroit MI, Toledo OH, London,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Cleveland OH, Akron OH, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Cleveland OH, Washington D.C. DC, Morristown NJ,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase1, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Cleveland OH, Parma OH, Beachwood OH,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
for
Coronary Allograft Vasculopathy (CAV)
Location: Cleveland OH
Sponsor: Genetesis Inc.
Sex: All
Age: 18+
Code: NCT05751915
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Cleveland OH, Mayfield Heights OH, Detroit MI,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)